Botanical species · safety record

Magnolia biondii

The EFSA Compendium of Botanicals holds 20 constituent measurements for Magnolia biondii. This page reports what those source records contain and how to reach them. It carries no effect estimate, no dose and no recommendation.

Accepted name in source: Magnolia biondii Pamp.

20Constituent measurements

0Safety records

6Cited sources

169Licensed products (Canada)

Also recorded as

Magnolia fargesii (Finet & Gagnep.) W.C.Cheng

Synonyms are carried from the source compendium. A species may be traded and studied under more than one name, which is exactly how a safety record gets lost.

Regulatory presence

Health Canada's Licensed Natural Health Products Database holds 169 licensed products naming Magnolia biondii as a medicinal ingredient, matched on the exact Latin binomial. A licence records that a product met the regulator's requirements for sale in Canada. It is not evidence that the product works.

Extract types on licence

Dry
Extract Type TBA

Source material stated

Dried flower buds
Flos
Flower
Flower buds
Magnolia biondii - Flower
New material
Volatile oils from flower
Whole plant

What the records describe

Constituents measured

Plant parts

Preparations

Recorded constituents

What analytical work has found in this species, at which plant part and preparation. A measured constituent is a fact about material, not about effect.

Substance	Plant part	Preparation	Concentration	Analytical method	Source
(+)-epiaschantin	Flower	Solvent extraction	—	Standard Chromatographic tests (paper- thin layer- and column chromatography)	Resolve DOI
1,8-cineole	Flower	Essential oil	≥ 13.23 Percent	Head space - solid phase micro extraction (HS-SPME)	Resolve DOI
1,8-cineole	Flower	Essential oil	≤ 38.02 Percent	Head space - solid phase micro extraction (HS-SPME)	Resolve DOI
Camphor	Flower	Essential oil	≥ 1.47 Percent	GC-FID	Resolve DOI
Camphor	Flower	Essential oil	≤ 40.66 Percent	GC-FID	Resolve DOI
Camphor	Flower	Essential oil	≥ 0.18 Percent	Head space - solid phase micro extraction (HS-SPME)	Resolve DOI
Camphor	Flower	Essential oil	≤ 43.26 Percent	Head space - solid phase micro extraction (HS-SPME)	Resolve DOI
Coumarins	Flower	Solvent extraction	—	HPLC-Decomp-HG-ICP-MS	Resolve DOI
Eleutheroside b	Flower	Solvent extraction	—	HPLC-Decomp-HG-ICP-MS	Resolve DOI
Lignans	Flower	Solvent extraction	—	Standard Chromatographic tests (paper- thin layer- and column chromatography)	Resolve DOI
Scopoletin	Flower	Solvent extraction	—	HPLC-Decomp-HG-ICP-MS	Resolve DOI
Scopolin	Flower	Solvent extraction	—	HPLC-Decomp-HG-ICP-MS	Resolve DOI
Sitostenone	Flower	Solvent extraction	—	Nuclear Magnetic Resonance (NMR)	Resolve DOI
1,8-cineole	Flower	Essential oil	≥ 16.73 Percent	GC-MS	No resolvable identifier
1,8-cineole	Flower	Essential oil	≤ 34.93 Percent	GC-MS	No resolvable identifier
Camphor	Flower	Essential oil	≥ 0.45 Percent	GC-MS	No resolvable identifier
Camphor	Flower	Essential oil	≤ 25.43 Percent	GC-MS	No resolvable identifier
Myrcene	Flower	Essential oil	≥ 0.78 Percent	GC-MS	No resolvable identifier
Myrcene	Flower	Essential oil	≤ 1.3 Percent	GC-MS	No resolvable identifier
Neolignans	Flower	Solvent extraction	—	Nuclear Magnetic Resonance (NMR)	No resolvable identifier

Cited sources

The literature the compendium cites for this species. Metatron Health has no relationship with these authors or journals and earns nothing from citing them.

Zeng, Zhi., Xie, Runqian., Zhang, Tao., Zhang, Han., Chen, Jie Yu. Analysis of Volatile Compositions of Magnolia biondii Pamp by Steam Distillation and Headspace Solid Phase Micro-extraction . Journal of oleo science, 2011, vol. 60, no. 12, p. 591-596. DOI
Jeong, Eun Sook., Choi, Kyu-Yeol., Kim, Sun-Chun., Son, In Seop., Cho, Hwang Eui., Ahn, Su Youn., Woo, Mi Hee., Hong, Jin Tae., Moon, Dong Cheul. Pattern recognition of the herbal drug, Magnoliae flos according to their essential oil components. Bulletin of the korean chemical society, 2009, p. 1121-1126.
Feng, W.-S., Wang, J.-C., He, Y.-H., Zheng, X.-K., Song, K., Zhang, Y.-L., Li, M., Zhao, W. Chemical constituents from the flower buds of Magnolia biondii Pamp.. Chinese pharmaceutical journal, 2015, vol. 50, no. 24, p. 2103-2106. DOI
Gao, Xuemei., Shen, Yanqiong., Yang, Liying., Shu, Lidang., Li, Ganpeng., Hu, Qiu-Fen. 8-O-4 '-Neolignans from Flower Buds of Magnolia fargesii and their Biological Activities. JOURNAL OF THE BRAZILIAN CHEMICAL SOCIETY, 2012, vol. 23, no. 7, p. 1274-+.
Lee, Jun., Kim, Nan Hee., Nam, Joo Won., Lee, Yun Mi., Jang, Dae Sik., Kim, Young Sook., Nam, Sang Hae., Seo, Eun-Kyoung., Yang, Min Suk., Kim, Jin Sook. Scopoletin from the Flower Buds of Magnolia fargesii Inhibits Protein Glycation, Aldose Reductase, and Cataractogenesis Ex Vivo. ARCHIVES OF PHARMACAL RESEARCH, 2010, vol. 33, no. 9, p. 1317-1323. DOI
Kim, Ji Sun., Kim, Jae Yeon., Lee, Hwa Jin., Lim, Hyo Jin., Lee, Da Yeon., Kim, Do Hee., Ryu, Jae-Ha. Suppression of Inducible Nitric Oxide Synthase Expression by Furfuran Lignans from Flower Buds of Magnolia fargesii in BV-2 Microglial Cells . Phytotherapy research, 2010, vol. 24, no. 5, p. 748-753. DOI

Boundary

A constituent measurement is a fact about material at a stated preparation, not a statement about what that material does in a person. An adverse-effect or genotoxicity record is an observation reported in a source, most often in an animal or laboratory model. Neither is a Metatron Health conclusion about causality, human risk or benefit, and the absence of a record is not proof that a preparation is safe. Nothing here is diagnosis, prescribing or individual medical care.

Continue

Independent literature